Welcome to our dedicated page for Neon Bloom news (Ticker: NBCO), a resource for investors and traders seeking the latest updates and insights on Neon Bloom stock.
Neon Bloom Inc. (NBCO) operates at the intersection of life-science innovation and secure financial technologies through subsidiaries like Bazelet Health Sales and Advanced Executive Sales. This news hub provides investors and analysts with essential updates on strategic acquisitions, regulatory developments, and technological advancements across both sectors.
Track NBCO’s progress in electronic payment processing, cannabis plant technology commercialization, and SAAS platform expansions. Our curated collection includes earnings reports, merger disclosures, product launch announcements, and SEC filings – all vital for understanding this diversified enterprise’s growth trajectory.
Key updates cover cross-industry synergies between fintech solutions and biotech innovations, compliance milestones for federally regulated technologies, and operational expansions in e-commerce infrastructure. Bookmark this page for real-time access to verified NBCO developments that impact both financial markets and emerging tech sectors.
Neon Bloom (OTC: NBCO) announces that its subsidiary Bazelet Health Systems has produced Cannabis America, a 100% THC-free cannabis plant. Tested by ACS Laboratory, this unique plant allows legal agricultural growth without the risk of THC contamination. Cannabis America offers versatile uses in industries like textiles, construction, and food production, contributing to carbon reduction as a natural purifier. Bazelet also develops PECSA™, a non-GMO food ingredient derived from this plant, targeting global markets. The company aims to fulfill the rising demand for zero-THC products in various sectors.
Neon Bloom Inc. (OTC: NBCO) has appointed Walter Tabaschek as Chief Operating & Financial Officer of its subsidiary, Bazelet Health Systems, Inc. Tabaschek joins from Bunge LTD., where he held significant roles, including COO of the Financial Services Group. He aims to spearhead Bazelet's operations and financial strategy, focusing on the marketing of PECSA™, a unique cannabis ingredient. Tabaschek is actively engaging investors at the Benzinga Cannabis Capital Conference, showcasing Bazelet's innovations in federally legal cannabis products.
Neon Bloom Inc. (OTC: NBCO) announces the launch of PECSA™, a first-to-market, federally legal cannabis ingredient developed by its subsidiary, Bazelet Health Systems, Inc. PECSA™, a plant-based, patent-pending ingredient, is designed for the food, drug, tobacco, and cosmetic industries and contains zero THC and CBD. It aims to support the Endocannabinoid System, potentially benefiting various health conditions. The ingredient will be supplied to enterprises interested in incorporating legal cannabinoid-derived ingredients into their products. PECSA™ is derived from the patented Pan2020 cannabis plant, ensuring compliance with federal regulations.
Neon Bloom, through its subsidiary Bazelet Health Systems, is enhancing the cannabis industry with non-psychoactive products. On January 3, 2022, the company received shareholder consent to amend its Articles of Incorporation, increasing its authorized shares to 750 million and creating 2 million shares of Series B Preferred stock. Bazelet is at the forefront of cannabis genome engineering, utilizing CRISPR technology to develop patented therapeutic plants that comply with federal regulations.
Neon Bloom (OTC: NBCO) has entered a licensing agreement with Floresta, LLC to cultivate Panakeia™ plants, unique cannabis genetics with 0.00% THC, at a facility in Tallahassee, Florida. This development positions Bazelet Health Systems, its subsidiary, to enhance its relationship with the FDA by supporting research on cannabis products. The initiative aims to contribute to FDA studies focused on the safety and efficacy of non-psychoactive cannabis. Additionally, part of the plants will support educational initiatives in cannabis research in Florida.
Bazelet Health Systems announced that its cannabis genetics excelled in Cornell University's "2021 Fiber and Dual-Purpose Strip Trials", leading in metrics like seed weight and germination rates. Notably, Bazelet's genetics had a seed weight over 20% greater than competitors and a germination rate of 88%. The varieties also reported nearly double the plant density, with heights 1.5 times taller than other strains. This success highlights Bazelet's commitment to developing non-psychoactive cannabis aimed at transforming agriculture and the food supply chain.
Bazelet Health Systems, a subsidiary of Neon Bloom (OTC:NBCO), has partnered with Sattviko to create a new line of superfoods infused with non-psychoactive cannabis ingredients. This collaboration aims to market healthy snacks that are diabetic-friendly, gluten-free, and packed with nutrients. The products will launch in the U.S. and globally in late 2021, supporting an expected growth in the superfoods market, projected to surpass $200 billion within five years. This partnership positions both companies at the forefront of the global superfood revolution.
Bazelet Research, a subsidiary of Neon Bloom (OTC: NBCO), has initiated advanced plant breeding for THC-Free cannabis cultivars aimed at regional adaptation in the Southeast U.S. The goal is to create safe 0.00% THC strains for the legal hemp market. The company boasts a 15,000 sf plant tissue culture lab and utilizes cutting-edge CRISPR gene-editing technology. Supported by the USDA, this initiative aims to enhance plant production and sustainable agriculture, addressing emerging demands in various industries.
Bazelet Oglesby, a subsidiary of Neon Bloom, Inc. (OTC: NBCO), has partnered with Mobile Hemp Drying Company (MHD) to enhance its Plant Science Service Plan. This collaboration will provide premium post-harvest hemp drying services utilizing advanced LMC Manufacturing equipment. MHD's system is designed to maintain optimal cannabinoid integrity during the drying process. CEO Ryan Kelly praised Bazelet's advancements in the hemp industry, while Bazelet’s Director, Kirk Calvert, highlighted the benefits of this service in terms of cost savings and risk reduction for customers.
Neon Bloom, Inc. (OTC: NBCO) announced on April 16, 2021, that Bazelet Oglesby has successfully planted its patented 0.00% THC Panakeia cannabis plants in South Georgia. This development marks Bazelet's entry into the Georgia cannabis market, utilizing a former golf course for crop production. Panakeia is the world's first patented cannabis plant with zero THC, making it compliant with federal law. Bazelet aims to provide safe and effective cannabinoid products for healthcare professionals, particularly as Georgia launches a low THC medical marijuana program.
